Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis

Journal of Nuclear Medicine

Volumn 39, Issue 7, 1998, Pages 1160-1166

  Yamada, Yoshihito ^b   Uchida, Yoshitaka ^b   Tatsumi, Koichiro ^a   Yamaguchi, Tetsuo ^b   Kimura, Hiroshi ^b   Kitahara, Hiroshi ^b   Kuriyama, Takayuki ^b  

^a CHIBA UNIVERSITY   (Japan)

^b NONE

Author keywords

Carbon 11 methionine; Fluorine 18 fluorodeoxyglucose; Mediastinum bilateral lymphadenopathy; PET; Sarcoidosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; FLUORODEOXYGLUCOSE F 18; GALLIUM 67; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; METHIONINE C 11; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LUNG HILUS; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CARBON RADIOISOTOPES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GALLIUM RADIOISOTOPES; HUMANS; LYMPHATIC DISEASES; MALE; MEDIASTINUM; METHIONINE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031816674     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fujiwara T, Matsuzawa T, Kubota K, et al. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography. J Nucl Med 1989;30:33-37.
2. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with PET: a prospective study. J Nucl Med 1990;31:1927-1932.
3. Leskinen-Kallio S, Nagren K, Lehikoinen P, Ruotsalainen U, Teras M, Joensuu H. Carbon-11-methionine and PET as an effective method to image head and neck cancer. J Nucl Med 1992;33:691-695.
4. Okada J, Yoshikawa K, Itami M, et al. PET using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferate activity. J Nucl Med 1992;33: 325-329.
5. Inoue T, Kim EE, Wong FCL, et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-L-methionine PET in detection of malignant tumors. J Nucl Med 1996;37:1472-1476.
6. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
7. Miyazawa H, Arai T, Iio M, Hara T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. J Nucl Med 1993;34:1886-1891.
8. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 1994;35:104-112.
9. Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995;36:252-258.
10. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue:a microautoradiographic comparison with FDG. J Nucl Med 1995;36:484-492.
11. DeRemee RA. The chest roentgenology of sarcoidosis. In: Lieberman J. ed. Sarcoidosis. Orlando: Grune and Stratton; 1985:117-135.
12. Meeting Report. Consensus conference: activity of sarcoidosis. Eur Respir J 1994;7: 624-627.
13. Reynolds HY. Bronchoalveolar lavage. Am Rev Respir Dis 1987;135:250-263.
14. Alavi A, Buchpiguel CA, Loessner A. Is there a role for FDG-PET imaging in the management of patients with sarcoidosis? J Nucl Med 1994;35:1650-1652.
15. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994;35:1647-1649.
16. Brudin LH, Valind SO, Rhodes CG, et al. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994;21: 297-305.
17. Israel HL, Karlin P, Menduke H, DeLisser OG. Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions. Ann NY Acad Sci 1986;465:609-618.
18. 11C] methionine. Jpn J Cancer Res 1989;80:778-782.
19. Daniele RP, Rossman MD, Kern JA, Elias JA. Pathogenesis of sarcoidosis. State of the Art Chest 1986;89:1745-1775.
20. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990;141:765-788.
21. Nagai S, Aung H, Takeuchi M, Kusume K, Izumi T. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 1991;99:674-680.
22. Takeuchi M, Nagai S, Nakada H, Aung H, Satake N, Kaneshima H, Izumi T. Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist. Clin Exp Immunol 1992;88:181-187.
23. Muller-Quernheim J, Pfeifer S, Mannel D, Strausz J, Ferlinz R. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992;145:187-192.
24. Yamaguchi E, Okazaki N, Tsuneta Y, Abe S, Terai T, Kawakami Y. Interleukins in pulmonary sarcoidosis. Dissociative correlations of lung interleukins 1 and 2 with the intensity of alveolitis. Am Rev Respir Dis 1988;138:645-651.
25. Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nucl Med 1994;21:57-81.